SCHEMBL6557784

SCHEMBL6557784

CC(=O)N[C@H](C)c1ccc(C(=O)O)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ACE2 Q9BYF1 4/20 0.41
ACACB O00763 3/20 0.40
GRM1 Q13255 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
NPC1 O15118 1/20 0.38
ACACA Q13085 1/20 0.37
BDKRB1 P46663 1/20 0.37
CHRNA1 P02708 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557788 1.00 LMNA (0.45) LMNAMAPK1HTTRAB9AL3MBTL1
SCHEMBL1076812 0.85 BDKRB1 (0.45) L3MBTL1ACACBMEN1CYP1A2KMT2A
SCHEMBL31187732 0.82 L3MBTL1 (0.48) HTTL3MBTL1ACACBKMT2A
SCHEMBL31359082 0.82 L3MBTL1 (0.48) HTTL3MBTL1ACACBKMT2A
SCHEMBL6557670 0.81 GRM1 (0.46) HTTRAB9AL3MBTL1ACE2ACACB
SCHEMBL6557665 0.81 GRM1 (0.46) HTTRAB9AL3MBTL1ACE2ACACB
SCHEMBL6558052 0.81 KMT2A (0.50) LMNAL3MBTL1ACE2ACACBGRM1
SCHEMBL6558054 0.81 KMT2A (0.50) LMNAL3MBTL1ACE2ACACBGRM1
SCHEMBL16045988 0.81 LMNA (0.41) LMNAL3MBTL1MEN1KMT2AHDAC1
SCHEMBL30202978 0.81 GPR139 (0.47) LMNAL3MBTL1ACACBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391454-A1 Substituted benzamide compounds with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2004-02-25 EP disclosed
EP-1195372-A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2002-04-10 EP disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
US-5958944-A TREATMENT OF CIRCULATORY DISEASES IN CORONARY, CEREBRAL, RENAL AND PERIPHERAL ARTERIES, AS A THERAPEUTIC AGENT FOR HYPERTENSION, ANGINA PECTORIS, AND RENAL AND PERIPHERAL CIRCULATION DISORDER, ANTIASTHMATIC AGENT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-09-28 US disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed